Omaveloxolone (RTA-408) is a potent Keap1 inhibitor and Nrf2 activator. It affects Nrf2/ARE and NF-κB signaling pathways by binding to Keap1 to prevent Nrf2 ubiquitination, effectively inhibiting oxidative stress, inflammation, and viral replication while promoting mitochondrial function and neuroprotection.
Omaveloxolone (RTA-408) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Omaveloxolone (RTA-408) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Omaveloxolone (RTA-408) Mechanism of Action: Keap1 Inhibition in Neuronal Cells Research
- Omaveloxolone (RTA-408) Clinical Trials
- Omaveloxolone (RTA-408) Working Concentration | Cell Culture | Treatment
- Omaveloxolone (RTA-408) Solubility in DMSO
- Omaveloxolone (RTA-408) Stock Solution
- Omaveloxolone (RTA-408) Storage
- Omaveloxolone (RTA-408) Stability
- Omaveloxolone (RTA-408) Combination Database
- Omaveloxolone (RTA-408) Molecular Weight
- Omaveloxolone (RTA-408) SMILES
- Omaveloxolone (RTA-408) CAS Number
- Omaveloxolone (RTA-408) Chemical Structure (2D and 3D)
- Omaveloxolone (RTA-408) Sigma (AMBH93E4C59A)? Try a better option.
- Omaveloxolone (RTA-408) MedChemExpress (HY-12212)? Try a better option.
- Omaveloxolone (RTA-408) Cayman (17854)? Try a better option.
- Omaveloxolone (RTA-408) APExBIO (B3576)? Try a better option.
- Omaveloxolone (RTA-408) SDS｜MSDS